News
Acute decompensated heart failure represents a heterogeneous group of disorders that typically present as dyspnea, edema and fatigue. Despite the high prevalence of this condition and its associated ...
Cardiorenal syndrome (CRS) commonly occurs during treatment of acute decompensated heart failure (ADHF) and is associated with poor clinical outcome. The pathophysiology of CRS entails a complex ...
Ultrafiltration (UF) provides the advantage of controlled volume removal, an isotonic filtrate in contrast to the hypotonicity of urine, and allows for a diuretic "holiday." Early clinical and ...
Initiating sacubitril-valsartan therapy in patients hospitalized with acute decompensated heart failure decreased N-terminal pro–B-type natriuretic peptide concentration and did not worsen renal ...
Decompensated heart failure (DHF) means that symptoms from heart failure are severe enough to require immediate medical attention. Dyspnea or shortness of breath is the most common symptom of DHF ...
Acute decompensated heart failure accounts for more than 1 million hospitalizations in the United States annually. 1 Rates of short-term unplanned rehospitalization and death associated with acute ...
Acute decompensated heart failure is characterized by new or worsening signs of heart failure such as shortness of breath, orthopnea, and volume overload that often lead to an emergency department ...
Among patients with acute decompensated heart failure, device-based thoracic duct decompression demonstrated the ability to reduce congestion safely, according to results of a first-in-human study ...
GALWAY, Ireland--(BUSINESS WIRE)--WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive data from 21 patients ...
A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure. JACC: Heart Failure , 2023; DOI: 10.1016/j.jchf.2023.09.029 Cite This Page : ...
About Acute Decompensated Heart Failure (ADHF) ADHF is an episode of worsening heart failure symptoms that results in millions of hospitalizations worldwide each year, ...
Early initiation of the sodium glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results